Stem-Cell Trial for Neurodegenerative Pediatric Disease to Get Under Way: The goal is a treatment for Batten disease, a rare and fatal disorder

Source: HealthDay News
Posted: September 22, 2006

Summary:

A phase I trial to test the safety of stem-cell transplants to treat Batten disease, a rare yet fatal inherited neurodegenerative disorder, is about to get started at Oregon Health & Science University's (OHSU) Doernbecher Children's Hospital.

Commentary: Hopefully this trial will provide new insights into using stem cells to treat neurological conditions, diseases and disorders in humans, maybe leading to other human trials using stem cells to treat such conditions.